Cardiac Arrhythmia
|
0.380 |
Biomarker
|
phenotype |
BEFREE |
Ibrutinib use, age, hypertension, and previous use of ACE inhibitors, angiotensin receptor blocker use, β blocker use, and aspirin use were independently associated with incident arrhythmias.
|
31208701 |
2019 |
Cardiac Arrhythmia
|
0.380 |
Biomarker
|
phenotype |
BEFREE |
Furthermore, in the Cox proportional hazard analysis, cTnI, but not ACE, IL2R or BNP, was a predictor of fatal arrhythmia in sarcoidosis patients (HR 2.418, P = 0.003).Higher ACE and sIL2-R are associated with systemic lesions, whereas BNP is a useful marker for detecting cardiac involvement in sarcoidosis patients. cTnI is a predictor of fatal arrhythmia in CS patients.
|
30101857 |
2018 |
Cardiac Arrhythmia
|
0.380 |
Biomarker
|
phenotype |
BEFREE |
The aim of the BRAVE study is to evaluate the effect of ramipril, an angiotensin-converting enzyme inhibitor, on ventricular myocardial remodeling and arrhythmia burden in patients with ARVD.
|
29574980 |
2018 |
Cardiac Arrhythmia
|
0.380 |
Biomarker
|
phenotype |
BEFREE |
The use of nitrates, angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, aldosterone antagonists, beta-blockers, digoxin, and positive inotropic drugs; treatment of arrhythmias and mechanical complications; and indications for use of implantable cardioverter-defibrillators and cardiac resynchronization is discussed.
|
28602369 |
2017 |
Cardiac Arrhythmia
|
0.380 |
GeneticVariation
|
phenotype |
BEFREE |
The angiotensin-converting enzyme (ACE) gene insertion or deletion in long-term hemodialysis patients may be associated with corrected QT interval prolongation, leading to fatal arrhythmias.
|
28575882 |
2017 |
Cardiac Arrhythmia
|
0.380 |
GeneticVariation
|
phenotype |
BEFREE |
The angiotensin-converting enzyme insertion/deletion (ACE I/D) polymorphism is described in association with numerous phenotypes, including arrhythmias, and may provide predictive value among pediatric patients undergoing congenital heart surgery.
|
24389577 |
2014 |
Cardiac Arrhythmia
|
0.380 |
Biomarker
|
phenotype |
BEFREE |
Angiotensin-converting enzyme (ACE)-related pathways influence arrhythmias and sudden cardiac arrest (SCA) risk.
|
19716087 |
2009 |
Cardiac Arrhythmia
|
0.380 |
Biomarker
|
phenotype |
CTD_human |
Mice with cardiac-restricted angiotensin-converting enzyme (ACE) have atrial enlargement, cardiac arrhythmia, and sudden death.
|
15331425 |
2004 |
Cardiac Arrhythmia
|
0.380 |
Biomarker
|
phenotype |
LHGDN |
Angiotensin converting enzyme and the arrhythmogenic action of angiotensin I: cardiac cell membrane as a site of angiotensin I conversion.
|
15256277 |
2004 |